Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria.
Purity:
>99.0%
CAS Number:
[2438203-51-9]
Target:
c-Kit
* VAT and and shipping costs not included. Errors and price changes excepted